These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9032160)

  • 1. Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study.
    Schneider DL; Barrett-Connor EL; Morton DJ
    JAMA; 1997 Feb; 277(7):543-7. PubMed ID: 9032160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid hormone use and bone mineral density in elderly women. Effects of estrogen.
    Schneider DL; Barrett-Connor EL; Morton DJ
    JAMA; 1994 Apr; 271(16):1245-9. PubMed ID: 7848399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in bone mineral density in 1653 men and women in the sixth through tenth decades of life: the Rancho Bernardo Study.
    Blunt BA; Klauber MR; Barrett-Connor EL; Edelstein SL
    J Bone Miner Res; 1994 Sep; 9(9):1333-8. PubMed ID: 7817816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
    Cundy T; Evans M; Roberts H; Wattie D; Ames R; Reid IR
    BMJ; 1991 Jul; 303(6793):13-6. PubMed ID: 1830502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density and history of oral contraceptive use.
    Fortney JA; Feldblum PJ; Talmage RV; Zhang J; Godwin SE
    J Reprod Med; 1994 Feb; 39(2):105-9. PubMed ID: 8169923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study.
    Greendale GA; Edelstein S; Barrett-Connor E
    J Bone Miner Res; 1997 Nov; 12(11):1833-43. PubMed ID: 9383688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasomotor symptoms are not associated with reduced bone mass in postmenopausal women: the Rancho Bernardo Study.
    von Mühlen DG; Soroko S; Kritz-Silverstein D; Barrett-Connor E
    J Womens Health Gend Based Med; 2000 Jun; 9(5):505-11. PubMed ID: 10883942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsteroidal anti-inflammatory drugs and bone mineral density in older women: the Rancho Bernardo study.
    Morton DJ; Barrett-Connor EL; Schneider DL
    J Bone Miner Res; 1998 Dec; 13(12):1924-31. PubMed ID: 9844111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin C supplement use and bone mineral density in postmenopausal women.
    Morton DJ; Barrett-Connor EL; Schneider DL
    J Bone Miner Res; 2001 Jan; 16(1):135-40. PubMed ID: 11149477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of estrogen treatment on bone mineral density of the spine, hip, wrist and total body in late postmenopausal women.
    Kohrt WM; Birge SJ
    Osteoporos Int; 1995 May; 5(3):150-5. PubMed ID: 7655174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of bone mineral density in the postmenopausal estrogen/progestin interventions trial.
    Marcus R; Greendale G; Blunt BA; Bush TL; Sherman S; Sherwin R; Wahner H; Wells B
    J Bone Miner Res; 1994 Sep; 9(9):1467-76. PubMed ID: 7817832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term assessment of forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
    Viola AS; Castro S; Marchi NM; Bahamondes MV; Viola CF; Bahamondes L
    Contraception; 2011 Aug; 84(2):122-7. PubMed ID: 21757052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of relationship between hip and spine bone mineral density and oral contraceptive use.
    Murphy S; Khaw KT; Compston JE
    Eur J Clin Invest; 1993 Feb; 23(2):108-11. PubMed ID: 8462619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between breast density and bone mineral density in never users of postmenopausal hormone therapy.
    Seckin B; Pekcan MK; Inal HA; Gulerman C
    Aging Clin Exp Res; 2017 Jun; 29(3):537-541. PubMed ID: 27294615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Benefit of Menopausal Hormone Therapy on Bone Density and Microarchitecture Persists After its Withdrawal.
    Papadakis G; Hans D; Gonzalez-Rodriguez E; Vollenweider P; Waeber G; Marques-Vidal PM; Lamy O
    J Clin Endocrinol Metab; 2016 Dec; 101(12):5004-5011. PubMed ID: 27854548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group.
    Cauley JA; Seeley DG; Ensrud K; Ettinger B; Black D; Cummings SR
    Ann Intern Med; 1995 Jan; 122(1):9-16. PubMed ID: 7985914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term estrogen replacement therapy in postmenopausal women sustains vertebral bone mineral density.
    Moore M; Bracker M; Sartoris D; Saltman P; Strause L
    J Bone Miner Res; 1990 Jun; 5(6):659-64. PubMed ID: 2382589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of postmenopausal estrogen therapy on bone density in elderly women.
    Felson DT; Zhang Y; Hannan MT; Kiel DP; Wilson PW; Anderson JJ
    N Engl J Med; 1993 Oct; 329(16):1141-6. PubMed ID: 8377776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappaB legend with bone mineral density in older adults: the Rancho Bernardo study.
    Stern A; Laughlin GA; Bergstrom J; Barrett-Connor E
    Eur J Endocrinol; 2007 May; 156(5):555-62. PubMed ID: 17468191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of predictors of bone mineral density and hip geometry in postmenopausal women: a cross-sectional study.
    Singh R; Gupta S; Awasthi A
    Arch Osteoporos; 2015; 10():39. PubMed ID: 26556785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.